 Marcelo Perraillon
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicare | 14 | 2023 | 666 | 2.870 |
Why?
| | Nursing Homes | 5 | 2019 | 136 | 1.500 |
Why?
| | Dementia | 4 | 2022 | 185 | 1.500 |
Why?
| | Preventive Health Services | 2 | 2023 | 134 | 1.320 |
Why?
| | Fee-for-Service Plans | 5 | 2023 | 79 | 1.320 |
Why?
| | Neoplasms | 5 | 2023 | 2118 | 1.130 |
Why?
| | Medicaid | 5 | 2023 | 411 | 1.060 |
Why?
| | United States | 31 | 2023 | 12297 | 0.910 |
Why?
| | Registries | 6 | 2023 | 1770 | 0.890 |
Why?
| | Comparative Effectiveness Research | 1 | 2023 | 130 | 0.810 |
Why?
| | Information Dissemination | 2 | 2022 | 193 | 0.800 |
Why?
| | Medical Record Linkage | 1 | 2021 | 53 | 0.750 |
Why?
| | Mental Status and Dementia Tests | 1 | 2021 | 20 | 0.740 |
Why?
| | Drug Costs | 1 | 2020 | 91 | 0.680 |
Why?
| | Insurance Coverage | 4 | 2023 | 204 | 0.680 |
Why?
| | Preventive Medicine | 1 | 2019 | 39 | 0.670 |
Why?
| | Research | 1 | 2022 | 396 | 0.630 |
Why?
| | Nootropic Agents | 1 | 2018 | 26 | 0.630 |
Why?
| | Medicare Part D | 1 | 2018 | 25 | 0.620 |
Why?
| | Quality Indicators, Health Care | 2 | 2017 | 287 | 0.600 |
Why?
| | Health Facility Administrators | 1 | 2017 | 4 | 0.600 |
Why?
| | Aged, 80 and over | 15 | 2020 | 6419 | 0.580 |
Why?
| | Aged | 22 | 2023 | 19255 | 0.580 |
Why?
| | Pneumonia | 4 | 2013 | 576 | 0.550 |
Why?
| | Homes for the Aged | 1 | 2016 | 19 | 0.530 |
Why?
| | Skilled Nursing Facilities | 4 | 2022 | 119 | 0.520 |
Why?
| | Healthcare Disparities | 2 | 2018 | 486 | 0.510 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 683 | 0.460 |
Why?
| | Clinical Coding | 2 | 2013 | 20 | 0.440 |
Why?
| | Humans | 42 | 2024 | 115611 | 0.420 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 963 | 0.400 |
Why?
| | Breast Neoplasms | 1 | 2023 | 1872 | 0.390 |
Why?
| | Internet | 1 | 2016 | 602 | 0.390 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2207 | 0.380 |
Why?
| | Antidepressive Agents | 2 | 2014 | 195 | 0.350 |
Why?
| | Antineoplastic Agents | 1 | 2020 | 1893 | 0.340 |
Why?
| | Alaska Natives | 2 | 2022 | 118 | 0.340 |
Why?
| | Female | 26 | 2024 | 59931 | 0.340 |
Why?
| | Health Care Costs | 3 | 2022 | 384 | 0.300 |
Why?
| | Stroke | 3 | 2019 | 1016 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1200 | 0.300 |
Why?
| | Colorado | 5 | 2024 | 4116 | 0.290 |
Why?
| | Male | 21 | 2022 | 55967 | 0.280 |
Why?
| | Socioeconomic Factors | 3 | 2018 | 1086 | 0.270 |
Why?
| | Community-Acquired Infections | 3 | 2013 | 141 | 0.250 |
Why?
| | Heart Failure | 4 | 2022 | 1964 | 0.250 |
Why?
| | Patient Discharge | 4 | 2023 | 770 | 0.240 |
Why?
| | Long-Term Care | 1 | 2015 | 76 | 0.240 |
Why?
| | Patient Readmission | 3 | 2023 | 609 | 0.240 |
Why?
| | Interviews as Topic | 2 | 2017 | 597 | 0.230 |
Why?
| | Insurance Claim Review | 2 | 2021 | 67 | 0.230 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2022 | 100 | 0.220 |
Why?
| | Hospitalization | 4 | 2023 | 1765 | 0.220 |
Why?
| | Early Medical Intervention | 1 | 2024 | 51 | 0.220 |
Why?
| | Health Surveys | 1 | 2015 | 446 | 0.220 |
Why?
| | Self-Injurious Behavior | 1 | 2014 | 114 | 0.210 |
Why?
| | Causality | 1 | 2023 | 106 | 0.210 |
Why?
| | Databases, Factual | 3 | 2021 | 1138 | 0.210 |
Why?
| | Diabetes Complications | 2 | 2021 | 212 | 0.210 |
Why?
| | Hormones | 1 | 2023 | 132 | 0.210 |
Why?
| | Anti-Infective Agents | 2 | 2022 | 225 | 0.200 |
Why?
| | State Government | 1 | 2022 | 41 | 0.200 |
Why?
| | Suicide, Attempted | 1 | 2014 | 316 | 0.190 |
Why?
| | Nervous System Malformations | 1 | 2022 | 34 | 0.190 |
Why?
| | Central Nervous System Infections | 1 | 2022 | 36 | 0.190 |
Why?
| | Nutritional Status | 1 | 2024 | 289 | 0.190 |
Why?
| | Case Management | 1 | 2021 | 62 | 0.190 |
Why?
| | Meningitis | 1 | 2022 | 74 | 0.180 |
Why?
| | Health Expenditures | 1 | 2022 | 173 | 0.180 |
Why?
| | Retrospective Studies | 9 | 2023 | 12608 | 0.180 |
Why?
| | Encephalitis | 1 | 2022 | 127 | 0.180 |
Why?
| | Hospital Mortality | 2 | 2013 | 779 | 0.180 |
Why?
| | Depression, Postpartum | 1 | 2022 | 102 | 0.180 |
Why?
| | Length of Stay | 2 | 2013 | 958 | 0.170 |
Why?
| | Hospice Care | 1 | 2023 | 186 | 0.170 |
Why?
| | Risk Factors | 6 | 2020 | 8699 | 0.170 |
Why?
| | SEER Program | 1 | 2020 | 195 | 0.170 |
Why?
| | Cost Savings | 1 | 2019 | 75 | 0.170 |
Why?
| | Antipsychotic Agents | 2 | 2008 | 183 | 0.160 |
Why?
| | Population Surveillance | 1 | 2022 | 395 | 0.160 |
Why?
| | Hip Fractures | 1 | 2009 | 75 | 0.160 |
Why?
| | Pregnant Women | 1 | 2019 | 132 | 0.160 |
Why?
| | Health Services Accessibility | 3 | 2022 | 772 | 0.150 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 526 | 0.150 |
Why?
| | Health Facility Closure | 1 | 2018 | 7 | 0.150 |
Why?
| | Economics, Hospital | 1 | 2018 | 19 | 0.150 |
Why?
| | Legislation, Food | 1 | 2017 | 2 | 0.150 |
Why?
| | Independent Living | 1 | 2018 | 84 | 0.150 |
Why?
| | Trans Fatty Acids | 1 | 2017 | 5 | 0.150 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 337 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1098 | 0.140 |
Why?
| | Cohort Studies | 2 | 2023 | 4945 | 0.140 |
Why?
| | Indians, North American | 1 | 2022 | 584 | 0.140 |
Why?
| | Residence Characteristics | 1 | 2018 | 276 | 0.130 |
Why?
| | Poverty | 1 | 2019 | 448 | 0.130 |
Why?
| | Smoking Cessation | 1 | 2019 | 377 | 0.130 |
Why?
| | Qualitative Research | 2 | 2022 | 975 | 0.130 |
Why?
| | Motivation | 1 | 2019 | 498 | 0.130 |
Why?
| | Awareness | 1 | 2016 | 92 | 0.130 |
Why?
| | Depressive Disorder, Major | 1 | 2008 | 304 | 0.120 |
Why?
| | Mass Screening | 1 | 2022 | 1024 | 0.120 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 88 | 0.120 |
Why?
| | Frail Elderly | 1 | 2015 | 105 | 0.120 |
Why?
| | Needs Assessment | 1 | 2016 | 318 | 0.120 |
Why?
| | Health Care Surveys | 1 | 2016 | 538 | 0.120 |
Why?
| | Physicians | 1 | 2022 | 776 | 0.110 |
Why?
| | Patient Compliance | 1 | 2007 | 524 | 0.110 |
Why?
| | Medication Adherence | 1 | 2008 | 538 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2018 | 477 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 906 | 0.110 |
Why?
| | Data Collection | 1 | 2016 | 636 | 0.110 |
Why?
| | Logistic Models | 3 | 2013 | 1856 | 0.100 |
Why?
| | Adult | 9 | 2023 | 30726 | 0.100 |
Why?
| | Health Personnel | 1 | 2017 | 582 | 0.100 |
Why?
| | Incidence | 3 | 2014 | 2335 | 0.090 |
Why?
| | Middle Aged | 8 | 2023 | 27014 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2015 | 576 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2017 | 931 | 0.090 |
Why?
| | Outpatients | 2 | 2011 | 330 | 0.070 |
Why?
| | Aging | 1 | 2016 | 1631 | 0.070 |
Why?
| | Drug Prescriptions | 2 | 2008 | 241 | 0.070 |
Why?
| | Comorbidity | 2 | 2011 | 1473 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 4438 | 0.060 |
Why?
| | Death | 1 | 2023 | 109 | 0.050 |
Why?
| | Subacute Care | 1 | 2023 | 70 | 0.050 |
Why?
| | United States Indian Health Service | 1 | 2022 | 42 | 0.050 |
Why?
| | Morbidity | 1 | 2022 | 278 | 0.050 |
Why?
| | Schools | 1 | 2024 | 400 | 0.050 |
Why?
| | Pharmaceutical Services | 1 | 2021 | 79 | 0.040 |
Why?
| | Child | 3 | 2024 | 18486 | 0.040 |
Why?
| | Age Distribution | 1 | 2011 | 341 | 0.040 |
Why?
| | Sex Distribution | 1 | 2011 | 337 | 0.040 |
Why?
| | Infant | 2 | 2024 | 7975 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2009 | 26 | 0.040 |
Why?
| | Observation | 1 | 2009 | 50 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2011 | 134 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2011 | 132 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2020 | 121 | 0.040 |
Why?
| | Diphosphonates | 1 | 2009 | 51 | 0.040 |
Why?
| | Respiratory Insufficiency | 1 | 2013 | 292 | 0.040 |
Why?
| | Bone Density Conservation Agents | 1 | 2009 | 62 | 0.040 |
Why?
| | Pregnancy | 2 | 2022 | 5550 | 0.040 |
Why?
| | Mortality | 1 | 2011 | 290 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2021 | 9159 | 0.040 |
Why?
| | Documentation | 1 | 2020 | 169 | 0.040 |
Why?
| | Estrogen Replacement Therapy | 1 | 2009 | 116 | 0.040 |
Why?
| | Drug Utilization | 1 | 2009 | 167 | 0.040 |
Why?
| | Disease Management | 1 | 2022 | 563 | 0.040 |
Why?
| | Odds Ratio | 1 | 2011 | 962 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2022 | 340 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1087 | 0.040 |
Why?
| | Sex Factors | 1 | 2013 | 1737 | 0.040 |
Why?
| | Models, Biological | 1 | 2014 | 1646 | 0.040 |
Why?
| | Inpatients | 1 | 2011 | 380 | 0.040 |
Why?
| | New York | 1 | 2017 | 109 | 0.040 |
Why?
| | Sepsis | 1 | 2013 | 515 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2021 | 686 | 0.030 |
Why?
| | Body Weight | 1 | 2020 | 867 | 0.030 |
Why?
| | Young Adult | 2 | 2019 | 10487 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2008 | 815 | 0.030 |
Why?
| | Age Factors | 1 | 2013 | 2907 | 0.030 |
Why?
| | Risk | 1 | 2008 | 819 | 0.030 |
Why?
| | Adolescent | 2 | 2014 | 17903 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 836 | 0.030 |
Why?
| | Communication | 1 | 2021 | 750 | 0.030 |
Why?
| | Consumer Behavior | 1 | 2015 | 66 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 959 | 0.030 |
Why?
| | Time Factors | 1 | 2014 | 6165 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 4668 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2578 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1485 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2017 | 3023 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 5059 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6264 | 0.020 |
Why?
|
|
Perraillon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|